Tower Research Capital LLC (TRC) - DECIPHERA PHARMACEUTICALS IN ownership

DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 144 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q4 2021. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of DECIPHERA PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$15,532
-83.8%
1,221
-82.1%
0.00%
-100.0%
Q2 2023$95,983
+223116.3%
6,817
+144.1%
0.00%
+200.0%
Q1 2023$43
-79.7%
2,793
-78.4%
0.00%
-88.9%
Q4 2022$212
-99.9%
12,936
+16.2%
0.01%
+200.0%
Q3 2022$206,000
+15.7%
11,134
-17.4%
0.00%
-25.0%
Q2 2022$178,000
+2.3%
13,478
-28.1%
0.00%
+100.0%
Q1 2022$174,000
-11.2%
18,745
-6.6%
0.00%
-33.3%
Q4 2021$196,000
+71.9%
20,076
+497.7%
0.00%0.0%
Q3 2021$114,000
+8.6%
3,359
+17.8%
0.00%0.0%
Q2 2021$105,000
-50.7%
2,852
-39.9%
0.00%
-25.0%
Q1 2021$213,000
+26.0%
4,745
+59.5%
0.00%
-20.0%
Q4 2020$169,000
+61.0%
2,974
+44.6%
0.01%
+400.0%
Q3 2020$105,000
-24.5%
2,056
-11.8%
0.00%
-83.3%
Q2 2020$139,000
+152.7%
2,332
+165.0%
0.01%
+20.0%
Q4 2019$55,000
+150.0%
880
+35.4%
0.01%
+150.0%
Q3 2019$22,000
-65.6%
650
-77.3%
0.00%
-50.0%
Q2 2019$64,000
+3100.0%
2,863
+5513.7%
0.00%
Q3 2018$2,000
-94.3%
51
-97.1%
0.00%
-100.0%
Q1 2018$35,000
+250.0%
1,758
+294.2%
0.00%
+200.0%
Q4 2017$10,0004460.00%
Other shareholders
DECIPHERA PHARMACEUTICALS IN shareholders Q4 2021
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 1,209,571$15,385,74319.76%
Redmile Group, LLC 4,475,384$56,926,8842.71%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 6,897,606$87,737,5481.93%
Parkman Healthcare Partners LLC 597,403$7,598,9661.39%
Ghost Tree Capital, LLC 325,000$4,134,0001.36%
BRAIDWELL LP 3,336,221$42,436,7311.34%
AlphaCentric Advisors LLC 132,000$1,679,0400.95%
ARMISTICE CAPITAL, LLC 4,612,000$58,664,6400.90%
Sunesis Advisors, LLC 96,299$1,224,9230.87%
EcoR1 Capital, LLC 993,000$12,630,9600.43%
View complete list of DECIPHERA PHARMACEUTICALS IN shareholders